Effect of intramuscular treatment with different iron dextran dosages and non-inferiority study to gleptoferron

Abstract Background Prevention of iron deficiency in suckling piglets by intramuscular injection of a standardized amount of iron dextran or gleptoferron in the first days of life can lead to over- or underdosage with respective health risks. Currently, combined iron products containing an active su...

Full description

Saved in:
Bibliographic Details
Main Authors: Isabel Hennig-Pauka, Martin Ganter, Dirk Bornhorn, Wesley Lyons, Enric Marco, Glen Almond, Bettina Schneider, Lothar Kreienbrock, Ken Steen Pedersen
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Acta Veterinaria Scandinavica
Subjects:
Online Access:https://doi.org/10.1186/s13028-024-00790-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559246729117696
author Isabel Hennig-Pauka
Martin Ganter
Dirk Bornhorn
Wesley Lyons
Enric Marco
Glen Almond
Bettina Schneider
Lothar Kreienbrock
Ken Steen Pedersen
author_facet Isabel Hennig-Pauka
Martin Ganter
Dirk Bornhorn
Wesley Lyons
Enric Marco
Glen Almond
Bettina Schneider
Lothar Kreienbrock
Ken Steen Pedersen
author_sort Isabel Hennig-Pauka
collection DOAJ
description Abstract Background Prevention of iron deficiency in suckling piglets by intramuscular injection of a standardized amount of iron dextran or gleptoferron in the first days of life can lead to over- or underdosage with respective health risks. Currently, combined iron products containing an active substance against coccidia are also used on farms. When using a combination product targeting two diseases, an adjustment of the necessary amount of iron to prevent anaemia in the frame of a farm-specific treatment protocol is not possible. The aim of this study was to test if iron dextran, which can be used in flexible volumes, is statistically non-inferior to a combinatory product, containing gleptoferron and toltrazuril. In addition, different administration schemes for iron dextran with respect to time point and dosage were compared on a conventional farm. Within each out of 17 litters eight healthy piglets were allocated to one of the four treatment groups on the second day of life: (1) 200 mg iron dextran, (2) 200 mg gleptoferron and 45 mg toltrazuril in combination, (3) 300 mg iron dextran, (4) 200 mg iron dextran and additional intramuscular administration of 200 mg iron dextran on day 11 of life. Pigs of groups 1, 3 and 4 received toltrazuril orally. Red blood cell measures were determined prior to treatment on day 2 of life and at weaning. Body weights were measured on day 2, 24, 74 and 160 of life. Results Iron dextran was non-inferior compared to gleptoferron within a tolerance range of ± 5 g haemoglobin/L. In total, treatment groups did not differ with respect to red blood cell parameters and average daily weight gain. The 50% pigs with intermediate birth weights profited from an additional iron dextran administration with respect to higher haemoglobin concentrations at weaning. Conclusions In this investigation gleptoferron and iron dextran appear equally appropriate for prevention of iron deficiency anaemia. Piglets of different birth weights might profit differently from an additional iron administration, so that usage of a product containing iron as a single substance is of advantage to allow a flexible adjustment of dosage during the suckling period.
format Article
id doaj-art-dd90cb4347df458ebe904307851699ae
institution Kabale University
issn 1751-0147
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Acta Veterinaria Scandinavica
spelling doaj-art-dd90cb4347df458ebe904307851699ae2025-01-05T12:42:07ZengBMCActa Veterinaria Scandinavica1751-01472025-01-0167111710.1186/s13028-024-00790-6Effect of intramuscular treatment with different iron dextran dosages and non-inferiority study to gleptoferronIsabel Hennig-Pauka0Martin Ganter1Dirk Bornhorn2Wesley Lyons3Enric Marco4Glen Almond5Bettina Schneider6Lothar Kreienbrock7Ken Steen Pedersen8Field Station for Epidemiology, University of Veterinary Medicine Hannover, FoundationClinic for Swine, Small Ruminants, Forensic Medicine and Ambulatory Service, University of Veterinary Medicine Hannover, FoundationField Station for Epidemiology, University of Veterinary Medicine Hannover, FoundationPharmacosmos Inc.Marco Vetgrup SLPCollege of Veterinary Medicine, North Carolina State UniversityInstitute for Biometry, Epidemiology and Information Processing, University of Veterinary Medicine Hannover, FoundationInstitute for Biometry, Epidemiology and Information Processing, University of Veterinary Medicine Hannover, FoundationDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of CopenhagenAbstract Background Prevention of iron deficiency in suckling piglets by intramuscular injection of a standardized amount of iron dextran or gleptoferron in the first days of life can lead to over- or underdosage with respective health risks. Currently, combined iron products containing an active substance against coccidia are also used on farms. When using a combination product targeting two diseases, an adjustment of the necessary amount of iron to prevent anaemia in the frame of a farm-specific treatment protocol is not possible. The aim of this study was to test if iron dextran, which can be used in flexible volumes, is statistically non-inferior to a combinatory product, containing gleptoferron and toltrazuril. In addition, different administration schemes for iron dextran with respect to time point and dosage were compared on a conventional farm. Within each out of 17 litters eight healthy piglets were allocated to one of the four treatment groups on the second day of life: (1) 200 mg iron dextran, (2) 200 mg gleptoferron and 45 mg toltrazuril in combination, (3) 300 mg iron dextran, (4) 200 mg iron dextran and additional intramuscular administration of 200 mg iron dextran on day 11 of life. Pigs of groups 1, 3 and 4 received toltrazuril orally. Red blood cell measures were determined prior to treatment on day 2 of life and at weaning. Body weights were measured on day 2, 24, 74 and 160 of life. Results Iron dextran was non-inferior compared to gleptoferron within a tolerance range of ± 5 g haemoglobin/L. In total, treatment groups did not differ with respect to red blood cell parameters and average daily weight gain. The 50% pigs with intermediate birth weights profited from an additional iron dextran administration with respect to higher haemoglobin concentrations at weaning. Conclusions In this investigation gleptoferron and iron dextran appear equally appropriate for prevention of iron deficiency anaemia. Piglets of different birth weights might profit differently from an additional iron administration, so that usage of a product containing iron as a single substance is of advantage to allow a flexible adjustment of dosage during the suckling period.https://doi.org/10.1186/s13028-024-00790-6AnaemiaAverage daily weight gainBirth weightHaemoglobinPacked cell volume
spellingShingle Isabel Hennig-Pauka
Martin Ganter
Dirk Bornhorn
Wesley Lyons
Enric Marco
Glen Almond
Bettina Schneider
Lothar Kreienbrock
Ken Steen Pedersen
Effect of intramuscular treatment with different iron dextran dosages and non-inferiority study to gleptoferron
Acta Veterinaria Scandinavica
Anaemia
Average daily weight gain
Birth weight
Haemoglobin
Packed cell volume
title Effect of intramuscular treatment with different iron dextran dosages and non-inferiority study to gleptoferron
title_full Effect of intramuscular treatment with different iron dextran dosages and non-inferiority study to gleptoferron
title_fullStr Effect of intramuscular treatment with different iron dextran dosages and non-inferiority study to gleptoferron
title_full_unstemmed Effect of intramuscular treatment with different iron dextran dosages and non-inferiority study to gleptoferron
title_short Effect of intramuscular treatment with different iron dextran dosages and non-inferiority study to gleptoferron
title_sort effect of intramuscular treatment with different iron dextran dosages and non inferiority study to gleptoferron
topic Anaemia
Average daily weight gain
Birth weight
Haemoglobin
Packed cell volume
url https://doi.org/10.1186/s13028-024-00790-6
work_keys_str_mv AT isabelhennigpauka effectofintramusculartreatmentwithdifferentirondextrandosagesandnoninferioritystudytogleptoferron
AT martinganter effectofintramusculartreatmentwithdifferentirondextrandosagesandnoninferioritystudytogleptoferron
AT dirkbornhorn effectofintramusculartreatmentwithdifferentirondextrandosagesandnoninferioritystudytogleptoferron
AT wesleylyons effectofintramusculartreatmentwithdifferentirondextrandosagesandnoninferioritystudytogleptoferron
AT enricmarco effectofintramusculartreatmentwithdifferentirondextrandosagesandnoninferioritystudytogleptoferron
AT glenalmond effectofintramusculartreatmentwithdifferentirondextrandosagesandnoninferioritystudytogleptoferron
AT bettinaschneider effectofintramusculartreatmentwithdifferentirondextrandosagesandnoninferioritystudytogleptoferron
AT lotharkreienbrock effectofintramusculartreatmentwithdifferentirondextrandosagesandnoninferioritystudytogleptoferron
AT kensteenpedersen effectofintramusculartreatmentwithdifferentirondextrandosagesandnoninferioritystudytogleptoferron